Breast cancer mortality has not declined in women over 85

January 16, 2013
Since 1992 the number of deaths linked to breast cancer in Spain has decreased among young and middle aged patients, but not among the elderly. Credit: SINC

Since 1992 the number of deaths linked to breast cancer in Spain has decreased among young and middle aged patients but not among the elderly. Spanish researchers also predict that it will continue to decline over the next decade, although more slowly as observed up until now.

A new study headed by a team of Spanish researchers has analysed in Spain among different age groups from 1981 to 2007, setting a valid prediction up until 2023.

Studying this age-related tendency is interesting because any improvement could have significant social and , especially in terms of the development of specific .

"We used the Lee-Carter model to examine the data. This model is normally used to study general but rarely employed to study mortality as a result of specific causes," as explained to SINC by Alejandro Álvaro Meca, lead author of the study and researcher at the department of and Public Health at the Rey Juan Carlos University in Madrid.

Published in the 'Public Health' journal, the results confirm that associated mortality increased with age, whereas in the different age groups it has decreased over time. The study shows an increase in breast cancer mortality in Spain from 1981 to 1992 and then a decrease from 1993 to 2007.

This could be due to the global increase in mammographies in women over the age of 45, which has increased early and improved survival rates as a result.

"The new results support this : there is an evident decrease in breast cancer mortality in women under the age of 50," state the authors.

A slower decrease for the future

The last stage of the Lee-Carter model involves predicting mortality in the future: up until 2023 in this case. Álvaro Meca suggests that the death rate will decrease but will not be so marked as in the past.

"Predictions show that rates will decrease more slowly. Mortality will decrease in all age groups but will not be the same for all. A more significant decrease will be observed amongst the youngest women, with a great difference in middle aged women where stabilisation is predicted and then even an increase amongst elderly women (85 years or over)," adds the researcher.

The results fall in line with those of other studies conducted in Spain. However, research studying mortality in is still scarce.

"Although this decrease trend will continue into the future, everything points to a stabilisation in mortality for elderly women," points out Álvaro Meca. "Therefore, breast cancer preventative practices should be different and specific to the age range of the patient," he concludes.

The reason behind this tendency

Breast cancer incidence has increased in all European countries in recent years, independently of whether or not national screening programmes are in place. However, mortality has experienced an annual decrease of 1.8% from 1997 to 2006.

This tendency is due to mammographies and the application of effective hormone treatments, chemotherapy and advances in radiotherapy and surgery.

According to Spain's 2006 National Health Survey, 4% of women between the age of 25 and 34 and 19% between the age of 35 and 44 undergo a mammography every two years.

"It is probable that such innovation has contributed to improved observed in Europe, although the contribution of each factor is unknown," indicate the authors.

Explore further: Risk of death from breast cancer higher among older patients

More information: Álvaro-Meca A, et al.: "Breast cancer mortality in Spain: Has it really declined for all age groups?" Public Health (2012), dx.doi.org/10.1016/j.puhe.2012.05.031

Related Stories

Risk of death from breast cancer higher among older patients

February 7, 2012
Among postmenopausal women with hormone receptor-positive breast cancer, increasing age was associated with a higher risk of death from breast cancer, according to a study in the February 8 issue of JAMA.

Polymorphism in opioid gene affects breast cancer survival

March 30, 2012
(HealthDay) -- Genotype at the A118G polymorphism of the µ-opioid receptor gene is associated with breast cancer-specific mortality, according to a study published in the April issue of Anesthesiology.

CDC: breast cancer mortality higher in black women

November 15, 2012
(HealthDay)—With earlier detection and better treatment, the mortality rate from breast cancer has fallen over the last two decades; black women, however, still die from the disease at a disproportionately higher rate than ...

Recommended for you

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.